These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 38605227)

  • 1. Exosomes for neurodegenerative diseases: diagnosis and targeted therapy.
    Tao H; Gao B
    J Neurol; 2024 Jun; 271(6):3050-3062. PubMed ID: 38605227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
    Jarmalavičiūtė A; Pivoriūnas A
    Pharmacol Res; 2016 Nov; 113(Pt B):816-822. PubMed ID: 26855317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis.
    Rastogi S; Sharma V; Bharti PS; Rani K; Modi GP; Nikolajeff F; Kumar S
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
    Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin.
    Younas N; Fernandez Flores LC; Hopfner F; Höglinger GU; Zerr I
    Transl Neurodegener; 2022 May; 11(1):28. PubMed ID: 35527262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome Biomarkers Revolutionize Preclinical Diagnosis of Neurodegenerative Diseases and Assessment of Treatment Responses in Clinical Trials.
    Kapogiannis D
    Adv Exp Med Biol; 2020; 1195():149. PubMed ID: 32468469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases.
    Nouri Z; Barfar A; Perseh S; Motasadizadeh H; Maghsoudian S; Fatahi Y; Nouri K; Yektakasmaei MP; Dinarvand R; Atyabi F
    J Nanobiotechnology; 2024 Aug; 22(1):463. PubMed ID: 39095888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities.
    Wang S; Dong Y; Gong A; Kong H; Gao J; Hao X; Liu Y; Wang Z; Fan Y; Liu C; Xu W
    Int J Biol Sci; 2021; 17(2):562-573. PubMed ID: 33613113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine.
    Lopes D; Lopes J; Pereira-Silva M; Peixoto D; Rabiee N; Veiga F; Moradi O; Guo ZH; Wang XD; Conde J; Makvandi P; Paiva-Santos AC
    Mil Med Res; 2023 Apr; 10(1):19. PubMed ID: 37101293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Wang X; Zhou Y; Gao Q; Ping D; Wang Y; Wu W; Lin X; Fang Y; Zhang J; Shao A
    Oxid Med Cell Longev; 2020; 2020():3232869. PubMed ID: 33193999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
    Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
    Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies.
    Bahadorani M; Nasiri M; Dellinger K; Aravamudhan S; Zadegan R
    Int J Nanomedicine; 2024; 19():7137-7164. PubMed ID: 39050874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Role of Exosome in Neurodegenerative Diseases: A Review Study.
    Sheykhhasan M; Heidari F; Farsani ME; Azimzadeh M; Kalhor N; Ababzadeh S; Seyedebrahimi R
    Curr Stem Cell Res Ther; 2024; 19(6):852-864. PubMed ID: 37496136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating exosomal MicroRNAs: New non-invasive biomarkers of non-communicable disease.
    Jiménez-Avalos JA; Fernández-Macías JC; González-Palomo AK
    Mol Biol Rep; 2021 Jan; 48(1):961-967. PubMed ID: 33313972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of exosomes in central nervous system tissue regeneration and repair.
    Wang J; Yang L
    Biomed Mater; 2023 Jul; 18(5):. PubMed ID: 37399812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases.
    Sharma V; Nikolajeff F; Kumar S
    Transl Neurodegener; 2023 Feb; 12(1):7. PubMed ID: 36747288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on exosomes and their non-coding RNAs in the diagnosis of neurodegenerative diseases].
    Wang BP; Pi Y; Chen M; Chang K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Sep; 58(9):1415-1422. PubMed ID: 39290025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progresses in exosome-based systems for targeted drug delivery to the brain.
    Bashyal S; Thapa C; Lee S
    J Control Release; 2022 Aug; 348():723-744. PubMed ID: 35718214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.